99.4% Purity
In Stock
BPC-157 / TB500 (5 mg / 5 mg)
- BPC-157 5mg / TB-500 5mg research blend for laboratory studies
- Pharmaceutical-grade dual peptide for in-vitro research only
- Not for human consumption
$70.00
Recovery & Healing
Peptides studied for tissue repair, cellular recovery, and regenerative research applications.
7 products found
99.4% Purity
In Stock
TB-500 (Thymosin Beta-4) (43aa)
- Thymosin Beta-4 Derivative: 43-amino acid peptide (Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES-OH), derived from naturally occurring thymosin beta-4 (70-80% of beta-thymosins), 2,000+ publications, N-terminal acetylation for enhanced stability
- Multi-Pathway Regeneration: G-actin sequestration (Kd 0.5-0.7 μM), cell migration promotion, VEGF upregulation via Wnt/β-catenin/Lef-1, angiogenesis, PI3K/Akt/eNOS survival pathway, anti-fibrotic via TGF-β1 suppression
- Clinical Status: No FDA-approved human drug, all therapeutic data preclinical (wound healing, cardiac repair, pulmonary fibrosis, Alzheimer's neuroprotection), extensive safety profile in animal models
$36.40
99.4% Purity
In Stock
MOTS-c (40mg)
- MOTS-c mitochondrial-derived peptide (40mg)
- 16-AA sequence MRWQEMGYIFYPRKLR, C₁₀₁H₁₅₂N₂₈O₂₂S₂, ~2,174 Da, CAS 1627580-64-6
- AMPK activator via folate-AICAR pathway
$110.00
99.4% Purity
In Stock
SS-31 (25mg)
- Synthetic mitochondria-targeted tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that selectively concentrates 5,000-fold at inner mitochondrial membrane through high-affinity cardiolipin binding
- FDA-approved September 2025 as Forzinity for Barth syndrome — first FDA-approved mitochondria-targeted therapeutic
- Extensively validated in 200+ peer-reviewed publications spanning cardiac, renal, neurological, and musculoskeletal research; multiple Phase 2/3 clinical trials completed
$0.00
99.4% Purity
In Stock
DSIP (5mg)
- Nonapeptide Neuromodulator: 9-amino acid sequence (WAGGDASGE), ≥98% purity
- Sleep Architecture: Delta-wave EEG activity induction without REM suppression or sedation
- Multisystem Research: 200+ publications (1977-2026), validated in double-blind human trials
$30.00
99.4% Purity
In Stock
Dileucine Capsules (2000mg) 50 Count
- Leucine Dipeptide: Two L-leucine residues (Leu-Leu), 244.33 Da, ≥98% purity
- PEPT1 Transport System: Active absorption via proton-coupled peptide transporter in small intestine
- Muscle Protein Synthesis: Enhanced mTORC1 activation and 42% greater anabolic response versus free leucine
$1.00
99.4% Purity
In Stock
Inflammation Defense Protocol
- BPC-157, TB-500, and MOTS-c bundled together for comprehensive recovery research
$0.00